Author

Luangyot Thongthieang

Observed name: L. Thongthieang

Institution: Khon Kaen Hospital

Observed institutions: Khon Kaen University, Khon Kaen Hospital

ORCID: 0009-0007-7354-9247

Observed ORCID: 0009-0007-7354-9247

OpenAlex ID: A5081772260

Real-life clinical pattern, management, and survival in Thai patients with early-stage or metastatic triple-negative breast cancer

2018 · Vichien Srimuninnimit, Piti Pornpraserthsuk, et al. · PLoS ONE · 9

Efficacy of Combination Docetaxel and Nintedanib in Advanced Non-Small Cell Lung Cancer in Thailand: A Multicenter Study

2021 · Krittiya Korphaisarn, Pongwut Danchaivijitr, et al. · Frontiers in Oncology · 6

Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in the Thai population: a real-world, multicenter observational study

2025 · Piyada Sitthideatphaiboon, Thanyanan Reungwetwattana, et al. · Frontiers in Oncology · 2

1302P Treatment outcomes and safety of durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in Thai populations: A real-world, multi-center observational study

2023 · P. Sitthideatphaiboon, T. Reungwetwattana, et al. · Annals of Oncology · 1

Clinical Characteristics and Survival Outcomes in Patients with Cancer of Unknown Primary Site (CUP): A Retrospective Cohort Study

2026 · Luangyot Thongthieang · Journal of the Medical Association of Thailand

Correlation Between Cytidine Deaminase Polymorphism and Gemcitabine in Efficacy and Toxicity

2018 · Suda Vannaprasaht, Duanggamon Muengsaen, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society

The Effect of CytidineDeaminase Polymorphisms on Hematotoxicity in Thai Cancer Patients Treated with Gemcitabine-based Chemotherapy

2016 · Duanggamon Muengsaen, Suda Vannaprasaht, et al. · ศรีนครินทร์เวชสาร (Srinagarind Medical Journal)

Works count: 7

Citation count: 18

H-index: 2

I10-index: